Biomarkers – Multimedia

A brief overview of the Preclinical Testing Core of the MODEL-AD consortium.

Infections have detrimental effects on wound healing leading to chronic wound formation. The use of labskin,a living skin model, in combination with mass spectrometry imaging, provides a good model for assessing wound healing factors.

In this list we take a look at 7 promising developments in diagnostic technologies from 2017.

In this video, Wyss Founding Director Donald Ingber and Technology Development Fellow Kambez Benam explain how the integrated smoking device mimics normal cigarette smoke exposure and how it can impact research into the causes of COPD and into new biomarkers and therapeutics.

The self-powered, paper-based electrochemical devices, or SPEDs, are designed for sensitive diagnostics at the “point-of-care,” or when care is delivered to patients, in regions where the public has limited access to resources or sophisticated medical equipment.

Data analysis process aiming at the identification of lipid biomarkers and the
evaluations of their performance.

In this study, the role of miRNAs has been assessed in a large cohort of pancreatic cancer.

This article highlights some of the wide range of applications which can be achieved using mass spectrometry.

In this talk, Matthias Nees discusses the development of cell culture model systems to recapitulate key aspects of cancer progression and to functionally validate biomarkers, target genes, and molecular signaling pathways.

The aim of this study is to understand the mechanism behind the association between single nucleotide polymorphisms (SNPs), lying in non-coding regions near or within RAD51B and RAD23B, and prostate cancer risk by analysing their interactions with the whole genome using Circular Chromosome Conformation Capture (4C).